İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023 · article

Empagliflozin and sacubitril/valsartan reverse methotrexate cardiotoxicity by repressing oxidative stress and hypoxia in heart embryonic H9c2 cardiomyocytes – the role of morphology of mitochondria observed on electron microscopy

Dergi Eur Rev Med Pharmacol Sci ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
ISSN2284-0729
YÖKSİS OpenAlex Açık erişim · green Üst %10
Yıl2023
Atıf14OpenAlex
Yüzdelik%90,6
FWCI2,441,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q2

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıEur Rev Med Pharmacol Sci
  • Katalog eşleşmesi (ISSN)European Review for Medical and Pharmacological Sciences (discontinued)
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

OBJECTIVE: Oxidative stress and hypoxia play an important role in the pathogenesis of various cardiovascular diseases. We aimed to evaluate the effectiveness of sacubitril/valsartan (S/V) and Empagliflozin (EMPA) on hypoxia-inducible factor-1α (HIF-1α) and oxidative stress in H9c2 rat embryonic cardiomyocyte cells. MATERIALS AND METHODS: BH9c2 cardiomyocyte cells were treated with methotrexate (MTX) (10-0.156 μM), empagliflozin (EMPA; 10-0.153 µM) and sacubitril/valsartan (S/V; 100-1.062 µM) for 24, 48 and 72 h. The half maximum inhibitory concentration (IC50) and half maximum excitation concentration (EC50) values of MTX, EMPA and S/V were determined. The cells under investigation were exposed to 2.2 μM MTX before treatment with 2 μM EMPA and 25 μM S/V. The cell viability, lipid peroxidation, oxidation of proteins and antioxidant parameters were measured while morphological changes were also observed by transmission electron microscopy (TEM). RESULTS: The results showed that treatment with 2 µM EMPA, 25 µM S/V or their combination produced a protective effect against the reduction in cell viability caused by 2.2 µM MTX. While HIF-1α levels plunged to their lowest with S/V treatment, oxidant parameters dipped, and antioxidant parameters soared to their highest level with S/V and EMPA combination treatment. A negative correlation was found between HIF-1α and total antioxidant capacity in the S/V treatment group. CONCLUSIONS: A significant decrease in HIF-1α and oxidant molecules together with an enhancement in antioxidant molecules and normalization of the mitochondria morphology as observed on electron microscopy in S/V and EMPA-treated cells were detected. Although S/V and EMPA have both protective effects against cardiac ischemia and oxidative damage, this effect may be increased more with S/V treatment alone compared to combined treatment.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

14atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 9 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2025 SGLT2 inhibitors: how do they affect the cardiac cellsAtıf 9 · OpenAlex
  2. 2024 Effect of dapagliflozin on oxidative stress in heart embryonic H9c2 cardiomyocytesAtıf 3 · OpenAlex
  3. 2024 Effect of dapagliflozin on oxidative stress in heart embryonic H9c2 cardiomyocytesAtıf 3 · OpenAlex
  4. 2024 Effects of the Methotrexate on HIF-1α, HIF-2α and P4H-TM Levels in Breast Cancer Cells: Results from an In Vitro StudyAtıf 1 · OpenAlex
  5. 2025 Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 CardiomyocytesAtıf 0 · OpenAlex
  6. 2025 Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 CardiomyocytesAtıf 0 · OpenAlex
  7. 2025 Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 CardiomyocytesAtıf 0 · OpenAlex
  8. 2025 Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 CardiomyocytesAtıf 0 · OpenAlex
  9. 2025 Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 CardiomyocytesAtıf 0 · OpenAlex

Yazarlar

8
  1. ZEKİ DOĞAN 1
  2. DİLEK DÜZGÜN ERGÜN İSTANBUL AYDIN ÜNİVERSİTESİ 2
  3. SİNEM DURMUŞ 3
  4. HAKAN ŞAHİN İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA 4
  5. GÖZDE ERKANLI ŞENTÜRK 5
  6. REMİSE GELİŞGEN 6
  7. Abdurrahman Şenyiğit 7
  8. HAFİZE UZUN 8